News / Taiwan / economic_daily
Emerging Stock Weekly: RegeneMed Leads Gains as Biotech Stocks Dominate
Health Technology · Biotechnology · economic_daily · 2026-09-18
7729
The Emerging Stock Board saw a strong week with RegeneMed surging 42.3% to top the rankings, while biotech firms secured eight of the top ten spots.
What Happened
Market Overview: The Taiwan stock market rebounded above the 47,000-point mark this week, lifting the Emerging Stock Board where 363 companies saw gains. The market averaged a 0.5% increase, reflecting improved investor sentiment and capital inflow across the board.
Biotech Dominance: Biotech stocks continued their strong performance, occupying eight of the top ten spots on the Emerging Stock Board this week. RegeneMed, a stem cell drug developer, led the pack with a 42.3% gain, marking its second consecutive week at the top.
Sector Diversification: Beyond the biotech sector, the top ten gainers also included companies from the sports and leisure and semiconductor industries. While biotech remains the primary focus for investors, capital is also flowing into other high-growth sectors.
Volatility and Risks: Despite the broad market rally, individual stock volatility remains a factor, as evidenced by Winged Advanced Technology hitting a trading halt. Several other companies, including Zhongzhi and Dingjin Biotech, also posted double-digit gains, highlighting the diverse performance across the board.